Attitudes Associated to Prescription of ADHD Drugs Among Child and Adolescent Psychiatrists in Region Skåne.

Attitude Clinical Trial

Official title:

Attitudes Associated to Prescription of ADHD Drugs Among Child and Adolescent Psychiatrists in Region Skåne.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04799886
• Other study ID #: RSLUAFADHD2021
• Status: Completed
• Start date: October 1, 2021
• Est. completion date: December 23, 2022

Study information

• Verified date: September 2023
• Source: Lund University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Each year Region Skåne in Sweden gathers information on drug prescriptions within the region. The last ten years a significant pattern of uneven prescription rates of ADHD drugs to people up to 17 years of age are noticed in the different districts. These regional differences are noticed in other regions in Sweden as well and internationally. The convention on the rights of the child became an institutional law in Sweden in 2020 and it emphasises that each child has the right to equal care and treatment. Therefore it is of importance to analyse how the variations in prescriptions rates arise and if we as healthcare providers can influence it. Our study is a collaboration between Region Skåne and the university of Lund and is a part of a larger study of the regional variations of prescriptions of ADHD drugs. Previous research informs us that a complex interplay of multiple factors can be behind variations in prescription rates among medical doctors and not the least subjective experiences and attitudes. Our study performs semistructured interviews of Region Skånes child and adolescent psychiatrists with questions specifically regarding their own experiences and attitudes that might influence their prescription behavior. The intention is to gather information that can guide future research questions.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 11
• Est. completion date: December 23, 2022
• Est. primary completion date: December 23, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• child and adolescent psychiatrist in Region Skåne

Exclusion Criteria:

• part of the research group

Related Conditions & MeSH terms

• ADHD - Combined Type
• Attitude
• Physician's Role

Intervention

Other:
• Semi structured interview
Interviews are performed by one research group member and based on beforehand decided questions and sub-questions. The interview material is transcribed and analysed on a theme level.

Locations

Country	Name	City	State
Sweden	Child and Adolescent Psychiatry, Region Skane	Malmö

Sponsors (2)

Lead Sponsor	Collaborator
Lund University	Region Skane

Country where clinical trial is conducted

Sweden, 

References & Publications (4)

Fulton BD, Scheffler RM, Hinshaw SP, Levine P, Stone S, Brown TT, Modrek S. National variation of ADHD diagnostic prevalence and medication use: health care providers and education policies. Psychiatr Serv. 2009 Aug;60(8):1075-83. doi: 10.1176/ps.2009.60.8.1075. — View Citation

Lindgren BM, Lundman B, Graneheim UH. Abstraction and interpretation during the qualitative content analysis process. Int J Nurs Stud. 2020 Aug;108:103632. doi: 10.1016/j.ijnurstu.2020.103632. Epub 2020 May 15. — View Citation

Mykletun A, Widding-Havneraas T, Chaulagain A, Lyhmann I, Bjelland I, Halmoy A, Elwert F, Butterworth P, Markussen S, Zachrisson HD, Rypdal K. Causal modelling of variation in clinical practice and long-term outcomes of ADHD using Norwegian registry data: the ADHD controversy project. BMJ Open. 2021 Jan 19;11(1):e041698. doi: 10.1136/bmjopen-2020-041698. — View Citation

Zetts RM, Stoesz A, Garcia AM, Doctor JN, Gerber JS, Linder JA, Hyun DY. Primary care physicians' attitudes and perceptions towards antibiotic resistance and outpatient antibiotic stewardship in the USA: a qualitative study. BMJ Open. 2020 Jul 14;10(7):e034983. doi: 10.1136/bmjopen-2019-034983. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Attitudes and experiences associated with prescription and diagnosis of ADHD	Semistructured interview	1 day (During the analysis of the transcribed interview)